News & Updates

Intravesical interferon instillation appears to benefit women with interstitial cystitis (IC), with a recent study showing that the approach helps improve patient-reported and objective outcomes compared with hyaluronic acid without serious adverse events.

Researchers have developed an artificial intelligence (AI)-enabled tool that can automatically detect vital steps during robotic-assisted radical prostatectomy (RARP) with high accuracy.

New drug applications approved by US FDA as of 1-15 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

An intervention using an electronic mobile health (mHealth) tool is not only feasible and acceptable but also delivers useful educational content and symptom management to patients undergoing radical cystectomy, according to a study.

Adherence to thiazide diuretics among patients with urolithiasis and hypercalciuria leads to fewer symptomatic stone events, as does adherence to alkali therapy among those with low urine pH, according to a retrospective cohort study.

The combination therapy of nivolumab plus cabozantinib (NIVO + CABO) continues to show long-term survival benefits and response rates over sunitinib at 55 months in patients with previously untreated advanced renal cell carcinoma (aRCC), according to updated results of the CheckMate 9ER study presented at ASCO GU 2024.